Keohavong P - Search Results

1

Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.

Stabile LP, Rothstein ME, Cunningham DE, Land SR, Dacic S, Keohavong P, Siegfried JM. Stabile LP, et al. Among authors: keohavong p. Carcinogenesis. 2012 Nov;33(11):2181-9. doi: 10.1093/carcin/bgs260. Epub 2012 Aug 2. Carcinogenesis. 2012. PMID: 22859269 Free PMC article.

2

Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.

Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem MF, Keohavong P. Gao WM, et al. Among authors: keohavong p. Carcinogenesis. 2003 Oct;24(10):1671-6. doi: 10.1093/carcin/bgg115. Epub 2003 Jul 4. Carcinogenesis. 2003. PMID: 12844488

3

Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients.

Liu Y, Lan Q, Siegfried JM, Luketich JD, Keohavong P. Liu Y, et al. Among authors: keohavong p. Neoplasia. 2006 Jan;8(1):46-51. doi: 10.1593/neo.05586. Neoplasia. 2006. PMID: 16533425 Free PMC article.

4

Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.

Gao WM, Romkes M, Siegfried JM, Luketich JD, Keohavong P. Gao WM, et al. Among authors: keohavong p. Mol Carcinog. 2006 Nov;45(11):828-32. doi: 10.1002/mc.20208. Mol Carcinog. 2006. PMID: 16865671

5

Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.

Zhang W, Stabile LP, Keohavong P, Romkes M, Grandis JR, Traynor AM, Siegfried JM. Zhang W, et al. Among authors: keohavong p. J Thorac Oncol. 2006 Sep;1(7):635-47. J Thorac Oncol. 2006. PMID: 17409930 Free article.

6

Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis.

Stabile LP, Rothstein ME, Keohavong P, Jin J, Yin J, Land SR, Dacic S, Luong TM, Kim KJ, Dulak AM, Siegfried JM. Stabile LP, et al. Among authors: keohavong p. Mol Cancer Ther. 2008 Jul;7(7):1913-22. doi: 10.1158/1535-7163.MCT-07-2169. Mol Cancer Ther. 2008. PMID: 18645002 Free PMC article.

7

Targeting of Both the c-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice.

Stabile LP, Rothstein ME, Keohavong P, Lenzner D, Land SR, Gaither-Davis AL, Kim KJ, Kaminski N, Siegfried JM. Stabile LP, et al. Among authors: keohavong p. Cancers (Basel). 2010 Dec 1;2(4):2153-70. doi: 10.3390/cancers2042153. Cancers (Basel). 2010. PMID: 21390244 Free PMC article.

8

K-ras mutations in lung tumors from NNK-treated mice with lipopolysaccharide-elicited lung inflammation.

Keohavong P, Kahkonen B, Kinchington E, Yin J, Jin J, Liu X, Siegfried JM, DI YP. Keohavong P, et al. Anticancer Res. 2011 Sep;31(9):2877-82. Anticancer Res. 2011. PMID: 21868532

9

KRAS and TP53 mutations in bronchoscopy samples from former lung cancer patients.

Gao W, Jin J, Yin J, Land S, Gaither-Davis A, Christie N, Luketich JD, Siegfried JM, Keohavong P. Gao W, et al. Among authors: keohavong p. Mol Carcinog. 2017 Feb;56(2):381-388. doi: 10.1002/mc.22501. Epub 2016 Jun 6. Mol Carcinog. 2017. PMID: 27182622

10

Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.

Liu Y, Gao W, Siegfried JM, Weissfeld JL, Luketich JD, Keohavong P. Liu Y, et al. Among authors: keohavong p. BMC Cancer. 2007 May 3;7:74. doi: 10.1186/1471-2407-7-74. BMC Cancer. 2007. PMID: 17477876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters